These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments. Choy W; Kim W; Nagasawa D; Stramotas S; Yew A; Gopen Q; Parsa AT; Yang I Neurosurg Focus; 2011 May; 30(5):E6. PubMed ID: 21529177 [TBL] [Abstract][Full Text] [Related]
4. Molecular genetics of meningiomas: from basic research to potential clinical applications. Simon M; Boström JP; Hartmann C Neurosurgery; 2007 May; 60(5):787-98; discussion 787-98. PubMed ID: 17460514 [TBL] [Abstract][Full Text] [Related]
6. A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas. Beauchamp RL; James MF; DeSouza PA; Wagh V; Zhao WN; Jordan JT; Stemmer-Rachamimov A; Plotkin SR; Gusella JF; Haggarty SJ; Ramesh V Oncotarget; 2015 Jul; 6(19):16981-97. PubMed ID: 26219339 [TBL] [Abstract][Full Text] [Related]
7. Molecular genetics of meningiomas: a systematic review of the current literature and potential basis for future treatment paradigms. Pham MH; Zada G; Mosich GM; Chen TC; Giannotta SL; Wang K; Mack WJ Neurosurg Focus; 2011 May; 30(5):E7. PubMed ID: 21529178 [TBL] [Abstract][Full Text] [Related]
8. The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP. Striedinger K; VandenBerg SR; Baia GS; McDermott MW; Gutmann DH; Lal A Neoplasia; 2008 Nov; 10(11):1204-12. PubMed ID: 18953429 [TBL] [Abstract][Full Text] [Related]
9. Molecular pathogenesis of meningiomas. Perry A; Gutmann DH; Reifenberger G J Neurooncol; 2004 Nov; 70(2):183-202. PubMed ID: 15674477 [TBL] [Abstract][Full Text] [Related]
10. Current standing and frontiers of gene therapy for meningiomas. De La Garza-Ramos R; Flores-Rodríguez JV; Martínez-Gutiérrez JC; Ruiz-Valls A; Caro-Osorio E Neurosurg Focus; 2013 Dec; 35(6):E4. PubMed ID: 24289129 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic and Therapeutic Strategy in Anaplastic (Malignant) Meningioma, CNS WHO Grade 3. Di Nunno V; Giannini C; Asioli S; Conti A; Furtner J; Balestrini D; Tosoni A Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230612 [No Abstract] [Full Text] [Related]
18. The role and regulatory mechanism of IL-1β on the methylation of the NF2 gene in benign meningiomas and leptomeninges. Wang B; Cui Z; Zhong Z; Sun Y; Yang GY; Sun Q; Bian L Mol Carcinog; 2016 Dec; 55(12):2268-2277. PubMed ID: 26840621 [TBL] [Abstract][Full Text] [Related]
19. Genetic/molecular alterations of meningiomas and the signaling pathways targeted. Domingues P; González-Tablas M; Otero Á; Pascual D; Ruiz L; Miranda D; Sousa P; Gonçalves JM; Lopes MC; Orfao A; Tabernero MD Oncotarget; 2015 May; 6(13):10671-88. PubMed ID: 25965831 [TBL] [Abstract][Full Text] [Related]
20. Familial meningioma: analysis of expression of neurofibromatosis 2 protein Merlin. Report of two cases. Maxwell M; Shih SD; Galanopoulos T; Hedley-Whyte ET; Cosgrove GR J Neurosurg; 1998 Mar; 88(3):562-9. PubMed ID: 9488313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]